Astex Pharmaceuticals Announces Expiration of HSR Waiting Period for Otsuka Tender Offer
October 07, 2013 at 06:06 AM EDT
Astex Pharmaceuticals, Inc. (Nasdaq: ASTX ) ("Astex"), announced today that the waiting period for U.S. antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, relating to the previously announced acquisition of Astex by Otsuka Pharmaceutical Co., Ltd (OTC: OTSKY ), expired on Friday, October 4,
